Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-06, Stock:LLY, The news for the past five days is as follows:
2020-01-30: NEWS1: Lilly Fends Off Sagging Drug Prices To Post Its Best Growth In 2 Years.NEWS2: Lilly's NDA for Selpercatinib Gets FDA's Priority Review.NEWS3: Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up.NEWS4: Eli Lilly beats profit estimates on strong demand for diabetes drug Trulicity.NEWS5: Eli Lilly Stock Is Climbing After a Glowing Earnings Report.NEWS6: Eli Lilly (LLY) Tops Q4 Earnings & Sales, Keeps 2020 View.NEWS7: Slapping Around Martin Shkreli Won’t Cut Drug Prices.NEWS8: Eli Lilly Earnings Top; Drug Giant Rises.NEWS9: Eli Lilly's stock gains after earnings, revenue rise above expectations.NEWS10: Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition.NEWS11: Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis.NEWS12: Eli Lilly Posts Earnings Beat on Strong Demand for Trulicity and Taltz.NEWS13: Stocks - Facebook Slumps, Verizon Slips in Premarket, Tesla Surges.
2020-01-31: NEWS1: Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study.NEWS2: Edited Transcript of LLY earnings conference call or presentation 30-Jan-20 2:00pm GMT.NEWS3: Eli Lilly prices migraine therapy at $640 for pack of eight pills.NEWS4: Lilly's REYVOW™ (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription.NEWS5: Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative.NEWS6: Bayer Seeks FDA Approval for New Formulation of Nifurtimox.NEWS7: The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO.NEWS8: CHMP Recommends Approval of Lilly's New Fast-Acting Mealtime Insulin to Improve Glycemic Control in Adults with Diabetes.
2020-02-03: NEWS1: Are You An Income Investor? Don't Miss Out On Eli Lilly and Company (NYSE:LLY).
2020-02-04: NEWS1: A Pick and Shovel Strategy to Avoid Competition and Speculation.NEWS2: Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal.NEWS3: Analysts Forecast Huge Upsides for Aimmune, Biohaven.NEWS4: 3 Dividend-Paying Stocks for Investors to Buy to Fight Off Market Uncertainty.
2020-02-05: NEWS1: Top Research Reports for Netflix, Eli Lilly & United Parcel Service.NEWS2: Here Are 4 Leading Pharmaceutical Stocks To Consider In Early 2020.NEWS3: Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?.

Answer: Decrease